Boston, MA -- (SBWIRE) -- 10/22/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: Medical Marijuana Inc(OTCMKTS:MJNA), Wells Fargo & Co(NYSE:WFC), Celldex Therapeutics, Inc.(NASDAQ:CLDX), Stereotaxis Inc(NASDAQ:STXS).
Medical Marijuana Inc(OTCMKTS:MJNA) opened its shares at the price of $0.14 for the day. Its closing price was $0.138 after losing-3.17% for the day. The company traded with the total volume of 5.45 million shares, while its average trading volume remained 6.32 million shares. The beta of MJNA stands at 4.92.
Medical Marijuana Inc. (MJNA) is the publicly held company vested in the medical marijuana and industrial hemp markets. It is comprised of a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries.
Has MJNA Found The Bottom and Ready To Move Up? Find Out Here
Wells Fargo & Co(NYSE:WFC) percentage change plunged -0.14% to close at $42.62 with the total traded volume of 16.46 million shares, and average volume of 19.84 million. The 52 week range of the stock remained $31.25 - $44.78, while its day lowest price was $42.52 and it hit its day highest price at $42.86.
Wells Fargo & Company is a bank holding company. The Company is a diversified financial services company. It has three operating segments: Community Banking, Wholesale Banking and Wealth, Brokerage and Retirement.
Has WFC Found The Bottom And Ready To Gain Momentum? Find Out Here
Celldex Therapeutics, Inc.(NASDAQ:CLDX) started its trading session with the price of $25.47 and closed at $23.46 by losing -9.07%. CLDX stocks traded with total volume of 5.61 million shares, while the average trading volume remained 3.41 million shares. The beta of CLDX stands at 2.12. Day range of the stock was $22.86 -$26.00.
Celldex Therapeutics, Inc. (Celldex), is a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases.
Why Should Investors Buy CLDX After the Recent Fall? Just Go Here and Find Out
Stereotaxis Inc(NASDAQ:STXS) ended its day with the gain of +8.22% and closed at the price of $3.82 after opening at $3.55. Stock traded during its last trading session with the total volume of 2.23 million shares, as compared to its average volume of 589,481 shares.
Stereotaxis, Inc. is a United States-based company that develops probes, devices, therapeutic and magnetic surgery delivery systems. The Company provides therapeutic delivery systems for the brain and central nervous system using magnetic stereotaxis.
Will STXS Get Buyers Even After The Recent Rally? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)